OERE-Summary-Writing-Guide_Checklist3 abbott2018
The Relationship between Student self –efficacy and Ability in Reading and Writing
Page 1
Research Summary Checklist
Before you begin
Tip: Ensure summary is relevant and useful to your target audience
It is important to have a clear understanding of your target audience before you begin writing a
summary. Your target audience will have specific professional needs and you will want to
consider why and how reading your research summary will help your target audience meet
their needs. Knowing your target audience will help you determine which research articles you
should prioritize for summary – for example, you may want to summarize research articles that
are directly relevant and useful to your target audience first – and will also help you clarify what
you should include in the “How you can use this research summary” (see p. 4 below).
Tip: Save time
Summaries will take between 4-6 hours (or longer) to write. To ensure time is not wasted, it is
useful to skim and scan each research article before writing, particularly the Abstract, Findings
and Conclusion sections. This will help you determine whether the research study is relevant
and useful to your target audience.
Further, depending on the needs of your target audience, you may not choose to summarize
the literature review section of the research article. For this reason, a summary writer may not
need to read this section in great depth.
Tip: Length
Summaries can vary in length and an appropriate balance needs to be found between providing
concise information in a brief summary without over simplifying the research and
compromising the quality of the summary. Generally, 2 to 4 pages are enough to capture the
key elements of an article.
Tip: Visuals
Include visuals whenever possible, as visuals are capable of summarizing a great deal of
information in a small space, and grab the reader’s attention. Make sure the visuals are easy to
read/understand, though. Poor or overly complex visuals may detract readers.
This summary writing checklist was developed by the OERE (http://oere.oise.utoronto.ca/) in order to increase the
efficiency of our summary writing process and the quality of our research summaries. The checklist was written by
Shasta Carr-Harris, Project Manager of the OERE, in consultation with the 2012 OERE summary writing team. It has
also been informed by an unpublished writing guide developed by the Centre for Addiction and Metal Health (CAMH)
(http://www.camh.ca/en/hospital/Pages/home.aspx), a Research Snapshot Template developed by the Research
Impact program at York University (http://www.researchimpact.ca/researchsearch/), which provides the basic structure
of all OERE summaries, and has been informed by Amara, Ouimet, & Landry (2004) and Nutley, Walter, & Davies
(2007) (see references below). For more information, please contact Shasta Carr-Harris at
shasta.carr.harris@utoronto.ca or via twitter @ShastaCH
http://oere.oise.utoronto.ca/
http://www.camh.ca/en/hospital/Pages/home.aspx
http://www.researchimpact.ca/researchsearch/
mailto:shasta.carr.harris@utoronto.ca
https://twitter.com/ShastaCH
Page 2
Headline
This is the “hook” that grabs the interest of the potential reader and entices them to read the
Snapshot. The headline can be a question which the Snapshot answers:
“Are girls really better readers?”
Or, it can be a simplified version of the article’s title:
“The Relationship between Student Self-Efficacy and Ability in Reading and Writing”
Tip: write the Headline near the end when you have a complete picture of the article and your
summary in mind.
What is this research about? (3-5 sentences)
Key things to include:
Highlight the purpose of the study
Include the research question (rewritten in plain language)
Define any terms necessary
What did the researchers do? (5-10 sentences)
This section is based on the methods/methodology section of the article.
Things to include:
How did the researchers collect data?
If the researchers administered a survey, provide details: online or paper
survey? Open-ended or close-ended questions used?
Provide examples of key questions asked (2-4 examples)
Page 3
Provide examples of answers participants had to choose from (2-3
examples to give the reader a sense of how participants could respond)
If interviews were conducted were these: in person, over the phone,
etc.? What were the key questions asked? Provide examples of
questions.
Note: the description of the questions asked in a survey or interview should match the purpose
of the study, as you have described it in the “What is this research about” section of the
summary.
Number of people sampled?
How were participants selected (inclusion/exclusion criteria)?
Final number of people who participated in the study?
Demographics (or other key characteristics) of the final participants in the
study?
Note: Importance of including sample size and participant characteristics
The number of participants included in the study and the characteristics of the final participants
are both critical pieces of information as they suggest how “generalizable” the findings from
this study are. That said, you may not find that every study includes this information. In this
case, you may want to contact the researcher for this information or you may want to draw
your audience’s attention to this in the summary by noting that this information is missing and
therefore the reader should be cautious when generalizing the findings.
What did the researchers find? (5-10 sentences)
Things to include:
Key findings from the study, rather than every finding from the study.
When describing findings make sure to make these as clear as possible by giving
specific details:
Numbers: how many people reported X? How many test results were
found to be X? etc;
Page 4
Provide a few examples whenever possible.
Instead of:
The researchers found that a majority of teachers had a positive view of the after school
literacy program.
Be specific:
The researchers found that the majority of teachers surveyed (35 out of 40) had a
positive view of the after school literacy program. Specifically, teachers reported that it
was easy to deliver as it did not require a lot of pre-planning or extra resources.
Tip: Bulleted lists
The nature of the results will determine the layout of this section. For a study with 3 or more
results it may be best to use a bulleted list, which can make the information more organized
and simpler to digest visually. Also, remember to be as specific as possible when presenting key
findings as this will help practitioners understand how this study is relevant to their practice.
How can you use this research? (3-7 sentences)
Identify who would be interested in the findings from this study (remember to focus on
your target audience). For example, if your target audience is educational practitioners
in schools you may want to include different ways that teachers, principals, vice
principals, and/or educational assistants can use the research.
Provide suggestions as to how this research can be used by practitioners. This section
may invite practitioners to use research conceptually or instrumentally. In either case,
any recommendations about how to use the research should follow logically from the
findings of the research study:
Conceptual use: research is used to shed light on situations and problems in one’s field of work
(Amara, Ouimet, Landry, 2004).
The research could help practitioners:
o Identify or understand issues/problems better or from different perspectives;
o Understand why action is required;
o Know which stakeholder can or should be consulted when addressing
issues/problems;
Page 5
o Understand the programs/policies/practices that can be used to address
issues/problems and in which context different programs/policies/practices are
most effective;
o Understand the different methods available to implement
programs/policies/practices, etc.;
(Adapted from Nutley, Walter, Davies, 2007)
Instrumental use: research has a direct impact on policy and/or practice decisions (Amara,
Ouimet, Landry, 2004).
The research may help practitioners take action to:
o Learn and implement evidence-based methods;
o Implement organizational programs/policies/practices based on research
evidence that can be used to address issues/problems;
o Consult with stakeholders to develop policies/programs/practices founded in
research evidence;
o Provide staff training that help practitioners learn evidence-based methods;
o Etc…
What you need to know (3-4 sentences):
This section is a very brief overview of the summary – what the study is about and an overview
of the findings. This section can be put into a highlighted box on the top right hand side of the
first page, so that practitioners can quickly decide whether this research summary will be useful
to them.
Example:
This study examined the factors that impact a young person’s decision to pursue
university education in Canada. The researchers found that family income and level of
parental education were important factors. The researchers also found an increasing
gender gap between male and female participation, with more young women attending
university than young men.
Page 6
Things to include:
1 sentence description of the study;
1-2 sentence general description of finding;
Original research article
You will want to provide readers with a citation and link to the full research article whenever
possible.
About the researchers
In this section, you can include a very brief bio (1-2 sentences) on each of the researchers.
References
Include any other references cited in article, if applicable.
Keywords
If you are adding your summaries to an online database, it is important to include key words
with which to “tag” each summary. Then, when practitioners search the database using these
key terms, their search will lead to the summary.
Tip: It is best to tag the summary with all relevant keywords to give your audience the greatest
chance of finding the summary when searching an online database.
About this summary
In this section you can include a very brief description of the team that developed the summary
and a link to your website.
Page 7
References
Amara, N., Ouimet, M., & Landry, R. (2004). New evidence on instrumental, conceptual,
and symbolic utilization of university research in government agencies. Science
Communication, 26(1), 75-106.
Nutley, S. M., Walter, I., & Davies, H. T. (2007). Using evidence: How research can inform public
services. The Policy Press.
British Journal of Anaesthesia, 120(1):
146
e155 (2018)
doi: 10.1016/j.bja.2017.08.002
Advance Access Publication Date: 23 November 2017
Quality and Safety
Q U A L I T Y A N D S A F E T Y
The surgical safety checklist and patient outcomes
after surgery: a prospective observational cohort
study, systematic review and meta-analysis
T.E.F. Abbott1, T. Ahmad1, M.K. Phull2, A.J. Fowler3, R. Hewson2,
B.M. Biccard4, M.S. Chew5, M. Gillies6 and R.M. Pearse1,*, for the
International Surgical Outcomes Study (ISOS) groupa
1William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK, 2The Royal
London Hospital, Barts Health NHS Trust, London E1 1BB, UK, 3Guys and St. Thomas’s NHS Foundation
Trust, London SE1 7EH, UK, 4Department of Anaesthesia and Perioperative Medicine, Groote Schuur
Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa, 5Department of
Anaesthesia and Intensive Care, Faculty of Medicine and Health Sciences, Link€oping University, 58185
Link€oping, Sweden and 6Department of Anaesthesia, Critical Care and Pain Medicine, University of
Edinburgh, Edinburgh EH48 3DF, UK
*Corresponding author. E-mail: r.pearse@qmul.ac.uk.
a Complete details for the collab authors are available in Supplementary data.
Abstract
Background: The surgical safety checklist is widely used to improve the quality of perioperative care. However, clinicians
continue to debate the clinical effectiveness of this tool.
Methods: Prospective analysis of data from the International Surgical Outcomes Study (ISOS), an international obser-
vational study of elective in-patient surgery, accompanied by a systematic review and meta-analysis of published
literature. The exposure was surgical safety checklist use. The primary outcome was in-hospital mortality and the
secondary outcome was postoperative complications. In the ISOS cohort, a multivariable multi-level generalized linear
model was used to test associations. To further contextualise these findings, we included the results from the ISOS
cohort in a meta-
analysis.
Results are reported as odds ratios (OR) with 95% confidence intervals.
Results: We included 44 814 patients from 497 hospitals in 27 countries in the ISOS analysis. There were 40 245 (89.8%)
patients exposed to the checklist, whilst 7508 (16.8%) sustained �1 postoperative complications and 207 (0.5%) died
before hospital discharge. Checklist exposure was associated with reduced mortality [odds ratio (OR) 0.49 (0.32e0.77);
P<0.01], but no difference in complication rates [OR 1.02 (0.88e1.19); P¼0.75]. In a systematic review, we screened 3732 records and identified 11 eligible studies of 453 292 patients including the ISOS cohort. Checklist exposure was associated
with both reduced postoperative mortality [OR 0.75 (0.62e0.92); P<0.01; I2¼87%] and reduced complication rates [OR 0.73 (0.61e0.88); P<0.01; I2¼89%). Conclusions: Patients exposed to a surgical safety checklist experience better postoperative outcomes, but this could simply reflect wider
quality of care in hospitals where checklist use is routine.
Editorial decision: August 21, 2017; Accepted: September 18, 2017
© 2017 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
For Permissions, please email: permissions@elsevier.com
146
mailto:r.pearse@qmul.ac.uk
https://doi.org/10.1016/j.bja.2017.08.002
mailto:permissions@elsevier.com
The surgical safety checklist and patient outcomes after surgery – 147
Key words: cohort studies; operative/mortality; postoperative care/methods; postoperative care/statistics and numerical
data; surgery; surgical procedures
Editor’s key points
� The surgical safety checklist is being promoted as an
effective tool to enhance patient safety
� This study provides outcome data from a large and
diverse collection of hospitals from around the world
� Surgical safety checklist use was associated with a
lower incidence of postoperative mortality, but not of
postoperative complications
� A pooled analysis of previous studies found that
checklist use was associated with a lower incidence of
both postoperative complications and death
More than 310 million surgical procedures are carried out
worldwide every year.1 Estimates of morbidity and mortality
vary.2e4 However, recent data suggest that approximately 75
million patients will experience a postoperative complication,
leading to two million deaths each year.5,6 An important cause
of avoidable harm is healthcare acquired illness or injury. In
the UK, perioperative adverse events account for one in six
patient safety incidents,7 and as many as half are potentially
avoidable.8 Preventable adverse events are costly in both hu-
man and financial terms. The UK Department of Health esti-
mates that iatrogenic harm costs the National Health Service
more than £1 billion each year,9 and other developed countries
are likely to be exposed to similar costs.
Checklists are a simple and reproducible way to stan-
dardize selected aspects of patient care. The World Health
Organisation (WHO) surgical safety checklist is the most
widely used surgical checklist, comprising 19 items in three
domains: before induction of anaesthesia, before surgical
incision, and before the patient leaves the operating theatre.
Actions include checks for a variety of items including patient
identity, introducing all team members, and antibiotic pro-
phylaxis.10 Since its inception, the checklist has been adopted
in >4000 hospitals worldwide,11 and is now considered a sur-
rogate marker for quality of patient care.12 However, there is
only limited evidence of any effect of checklist use on health
outcomes.12 A previous meta-analysis reported insufficient
high-quality evidence to draw robust conclusions, but there
have been further studies since this publication.12,13 Mean-
while, the clinical effectiveness of the surgical safety checklist
remains unclear and some clinicians object to its use.14,15
In the recent International Surgical Outcomes Study (ISOS)
we collected prospective data describing surgical safety
checklist use, along with patient outcomes following elective
in-patient surgery in 27 countries.6 Given the apparent wide-
spread and growing use of the surgical safety checklist and the
need for further evidence, we performed a prospective anal-
ysis of the effects of checklist exposure on postoperative pa-
tient outcomes. To contextualise the results of this analysis
and to describe the current evidence for this intervention, we
included these findings in a systematic review and meta-
analysis of the published literature.
Methods
This was a pre-planned secondary analysis of prospectively
collected data as part of ISOS. To complement this, we con-
ducted a systematic review of the existing literature and a
meta-analysis, in which we included the results of ISOS
analysis.
ISOS analysis: design, setting, and participants
ISOS was a 7-day international cohort study, the main results
of which have been reported previously.6 In the UK, the study
was approved by the Yorkshire and Humber Research Ethics
Committee (Reference: 13/YH/0371). In other countries, regu-
latory requirements varied with some requiring research
ethics approval and some requiring only data governance
approval. The inclusion criteria were all adult patients (age
�18 years) undergoing elective surgery with a planned over-
night stay in hospital. Each participating country selected a
single data collection week between April 2014 and August
2014. Patients undergoing emergency surgery, day-case sur-
gery, or radiological procedures were excluded. During the 1-
week study period, data were collected for consecutive pa-
tients until hospital discharge, using standardized paper case
record forms. Data included baseline demographic informa-
tion, details of the surgical procedure, postoperative care, and
in-hospital postoperative clinical outcomes. The use of the
surgical safety checklist was collected by study investigators
at each site as part of the core dataset. Data were censored at
30 days following surgery for patients who remained in hos-
pital. Data were anonymized and entered onto a purpose-built
secure internet database, which included automated checks
for plausibility, consistency, and completeness.
ISOS analysis: outcome measures
The primary outcome measure for the analysis of the ISOS
cohort was in-hospital mortality. The secondary outcome
measure was the presence of any postoperative in-hospital
complication assessed according to predefined criteria.6,16 A
patient with any of the following complications was deemed
to have met the secondary outcome: surgical site infection,
body cavity infection, pneumonia, urinary tract infection,
bloodstream infection, myocardial infarction, arrhythmia,
pulmonary oedema, pulmonary embolism, stroke, cardiac
arrest, gastro-intestinal bleed, acute kidney injury, post-
operative bleed, acute respiratory distress syndrome, anasto-
motic leak, or other un-categorized complications. The
severity of complications was graded as mild, moderate, or
severe.16
ISOS analysis: statistical methods
Data were included for hospitals returning valid data for �20
participants, and countries with at least 10 participating hos-
pitals. We dichotomized the sample according to the presence
Table 1 Baseline patient characteristics of patients included in the analysis of the prospective observational cohort (International
Surgical Outcomes Study). Data are presented as n (%) for categorical variables and as mean with standard deviation (SD) or median
with interquartile range (IQR) for continuous variables. Univariable association with exposure to surgical safety checklist presented as
odds ratios (OR) with 95% confidence interval (95% CI) and P-value. ASA, American Society of Anesthesiologists physical status score;
COPD, chronic obstructive pulmonary disease
Patients n (%) Checklist use (%) Did not use checklist (%) OR (95% CI) P-value
n ¼ 44 814 n ¼ 40 245 n ¼ 4538 e e
Age, median (IQR) 57 (43e69) 57 (43e69) 56 (41e68) 1.04 (0.87e1.23) 0.70
Male, n (%) 20 458 (45.7) 18 317 (45.5) 2125 (46.8) 0.95 (0.89e1.01) 0.13
Females, n (%) 24 351 (54.3) 21 927 (54.5) 2413 (53.2) 1.05 (0.98e1.13) 0.13
Present smoker, n (%) 7931 (17.8) 6942 (17.3) 965 (12.2) 1.04 (0.89e1.22) 0.64
ASA physical status n (%)
I 11 227 (25.1) 9973 (24.8) 1246 (27.5) 0.97 (0.81e1.16) 0.72
II 22 265 (49.8) 20 300 (50.5) 1956 (43.2) 1.08 (0.94e1.24) 0.28
III 10 193 (22.8) 8991 (22.4) 1194 (26.4) 1.06 (0.92e1.23) 0.41
IV 1038 (2.3) 908 (2.3) 130 (2.9) 0.90 (0.66e1.23) 0.51
Grade of surgery, n (%)
Minor 8411 (18.8) 7448 (18.5) 960 (21.2) 0.69 (0.63e0.77) <0.01
Intermediate 20 203 (45.1) 18 051 (44.9) 2137 (47.1) 0.93 (0.86e1.01) 0.11
Major 16 175 (36.1) 14 732 (36.6) 1438 (31.7) 1.54 (1.39e1.72) <0.01
Surgical specialty, n (%)
Orthopaedic 9459 (21.1) 8683 (21.6) 771 (17.0) 1.18 (1.01e1.39) 0.04
Breast 1538 (3.4) 1393 (3.5) 145 (3.2) 0.86 (0.63e1.18) 0.34
Obstetrics and gynaecology 5674 (12.7) 5123 (12.7) 547 (12.1) 0.92 (0.75e1.12) 0.40
Urology and kidney 4871 (10.9) 4299 (10.7) 570 (12.6) 0.92 (0.76e1.11) 0.37
Upper gastrointestinal 1986 (4.4) 1776 (4.4) 208 (4.6) 1.31 (0.99e1.73) 0.06
Lower gastrointestinal 3073 (6.9) 2711 (6.7) 360 (7.9) 1.06 (0.84e1.33) 0.63
Hepato-biliary 2282 (5.1) 1959 (4.9) 322 (7.1) 1.18 (0.91e1.53) 0.22
Vascular 1599 (3.6) 1436 (3.6) 161 (3.6) 1.17 (0.85e1.61) 0.32
Head and neck 6510 (14.5) 5913 (14.7) 592 (13.1) 0.88 (0.74e1.03) 0.11
Plastic or cutaneous 1670 (3.7) 1386 (3.5) 284 (6.3) 1.01 (0.78e1.31) 0.94
Cardiac 1716 (3.8) 1557 (3.9) 159 (3.5) 0.54 (0.39e0.75) <0.01
Thoracic (lung and other) 1157 (2.6) 1086 (2.7) 69 (1.5) 1.44 (0.95e2.18) 0.08
Other 3270 (7.3) 2919 (7.3) 350 (7.7) 0.88 (0.72e1.09) 0.24
Laparoscopic surgery, n (%) 7087 (15.8) 6472 (16.1) 610 (13.5) 1.37 (1.10e1.69) <0.01
Comorbid disorder, n (%)
Coronary artery disease 4588 (10.3) 3952 (9.8) 632 (14.0) 1.17 (0.94e1.46) 0.16
Heart failure 1882 (4.2) 1594 (4.0) 287 (6.3) 0.93 (0.70e1.25) 0.65
Diabetes mellitus 5171 (11.6) 4596 (11.4) 571 (12.6) 0.85 (0.70e1.03) 0.10
Cirrhosis 342 (0.8) 311 (0.8) 31 (0.7) 1.15 (0.56e2.37) 0.70
Metastatic cancer 1706 (3.8) 1547 (3.9) 159 (3.5) 0.90 (0.67e1.21) 0.48
Stroke 1492 (3.3) 1333 (3.3) 158 (3.5) 1.00 (0.72e1.39) 0.99
COPD 4094 (9.2) 3790 (9.4) 303 (6.7) 1.07 (0.85e1.35) 0.55
Other 3269 (7.3) 16 552 (41.2) 2042 (45.1) 1.00 (0.87e1.16) 0.95
Had a complication 7508 (16.8) 6734 (16.7) 768 (16.9) 1.04 (0.87e1.23) 0.70
In-hospital mortality 207 (0.5) 163 (0.4) 44 (1.0) 0.79 (0.36e1.73) 0.55
148 – Abbott et al.
or absence of surgical safety checklist use and presented
baseline demographic and clinical characteristics. The out-
comes were considered as binary categorical variables. In the
primary analysis, we assessed for associations between
exposure to a surgical safety checklist and postoperative
mortality, compared to no exposure to a surgical safety
checklist, before and after adjustment for potential con-
founding factors. For the adjusted analysis, we used a hierar-
chical two-level generalized linear model, with patients at the
first level and hospitals at the second level; a three-level model
with countries at the third level did not converge. We included
the following pre-specified covariates to adjust for potential
confounding factors: age, gender, current smoker, American
Society of Anesthesiologists physical status score, grade of
surgery, surgical procedure category, and presence of co-
morbid disease (coronary artery disease, heart failure, dia-
betes mellitus, chronic obstructive pulmonary disease/
asthma, cirrhosis, metastatic cancer, stroke, and other un-
specified chronic disease). These covariates were selected
for clinical plausibility and evidence of association with
the exposure or outcomes in previous epidemiological
research.4,17e19 The results are presented as odds ratios (OR)
with 95% confidence intervals (CI) and associated Wald P-
values. The primary analysis was repeated for in-hospital
complications as the secondary outcome measure, consid-
ered as a binary categorical variable using a three-level
generalized linear model, with patients at the first level, hos-
pitals at the second, and countries at the third level. Normally
distributed continuous variables are presented as mean with
standard deviation (SD), and non-normally distributed
continuous variables are presented as median with inter-
quartile range (IQR), and proportions are presented as n (%).
We used STATA version 14 (StataCorp LP, College Station, TX,
USA) for the statistical analysis.
Table 2 Results of the primary and secondary analyses of the prospective International Surgical Outcomes Study (ISOS) cohort.
Summary of two separate statistical models, where the dependent variables were either mortality or any postoperative complication
(excluding mortality). Generalized linear models, with results presented as odds ratios with 95% confidence intervals and P-values. All
variables were binary categorical unless otherwise stated, where exposure to a variable was compared to non-exposure. ASA physical
status and grade of surgery categorical variables where the reference was the average effect across the whole cohort. ASA, American
Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease
Any complication P-value Mortality P-value
Age (yr) 1.01 (1.00e1.01) <0.01 1.03 (1.02e1.04) <0.01 Male 1.05 (1.02e1.08) <0.01 1.03 (0.89e1.21) 0.67 Female 0.95 (0.93e0.98) <0.01 0.97 (0.83e1.13) 0.67 Present smoker 0.99 (0.92e1.07) 0.84 1.61 (1.12e2.31) 0.01 ASA physical status I 0.54 (0.49e0.58) <0.01 0.09 (0.02e0.39) <0.01 II 0.71 (0.67e0.75) <0.01 0.69 (0.39e1.22) 0.20 III 1.21 (1.14e1.29) <0.01 2.20 (1.29e3.76) <0.01 IV 2.17 (1.92e2.46) <0.01 7.54 (4.18e13.63) <0.01 Grade of surgery Minor 0.52 (0.49e0.56) <0.01 0.63 (0.43e0.93) 0.02 Intermediate 0.91 (0.87e0.96) <0.01 0.92 (0.71e1.21) 0.55 Major 2.10 (2.00e2.20) <0.01 1.72 (1.34e2.22) <0.01 Surgical specialty Orthopaedic 0.89 (0.83e0.96) <0.01 0.64 (0.41e0.98) 0.04 Breast 0.59 (0.49e0.70) <0.01 0.65 (0.17e2.42) 0.52 Obstetrics and gynaecology 0.77 (0.69e0.85) <0.01 0.80 (0.36e1.76) 0.57 Urology and kidney 0.83 (0.76e0.91) <0.01 0.48 (0.26e0.89) 0.02 Upper Gastrointestinal 1.37 (1.23e1.53) <0.01 2.79 (1.85e4.22) <0.01 Lower gastrointestinal 1.48 (1.34e1.62) <0.01 1.90 (1.27e2.84) <0.01 Hepatobiliary 0.97 (0.86e1.10) 0.67 1.61 (0.93e2.78) 0.09 Vascular 1.05 (0.93e1.19) 0.42 0.96 (0.56e1.64) 0.87 Head and neck 0.67 (0.62e0.74) <0.01 0.63 (0.36e1.11) 0.11 Plastic or cutaneous 1.01 (0.88e1.17) 0.85 0.94 (0.39e2.23) 0.88 Cardiac 2.49 (2.20e2.80) <0.01 1.47 (0.95e2.28) 0.09 Thoracic (lung and other) 1.25 (1.08e1.45) <0.01 1.19 (0.63e2.26) 0.59 Other 0.68 (0.60e0.77) <0.01 0.76 (0.37e1.58) 0.46 Comorbid disorder Coronary artery disease 1.04 (0.95e1.13) 0.44 0.99 (0.70e1.40) 0.96 Heart failure 1.28 (1.13e1.44) <0.01 1.59 (1.08e2.32) 0.02 Diabetes mellitus 1.10 (1.01e1.19) 0.02 1.24 (0.89e1.73) 0.20 Cirrhosis 1.45 (1.11e1.88) <0.01 2.77 (1.34e5.72) <0.01 Metastatic cancer 1.45 (1.28e1.64) <0.01 3.41 (2.25e5.19) <0.01 Stroke 1.16 (1.01e1.32) 0.03 2.79 (1.88e4.14) <0.01 COPD 1.13 (1.04e1.24) <0.01 1.13 (0.78e1.64) 0.52 Other 1.23 (1.15e1.31) <0.01 1.47 (1.07e2.01) 0.02 Exposure to checklist 1.02 (0.88e1.19) 0.75 0.49 (0.32e0.77) <0.01
The surgical safety checklist and patient outcomes after surgery – 149
ISOS analysis: sensitivity analyses
We were interested to assess whether countries with high
checklist usage, as a proportion of the total number of patients
(i.e. checklist compliance), were more likely to have lower risk
of in-hospital mortality or postoperative complications. We
calculated checklist compliance by country as the proportion
of patients in each country that were exposed to the checklist.
We ranked countries by compliance and divided the sample
into four similarly sized quartiles, with quartile one repre-
senting lowest compliance and quartile four representing
highest compliance. We repeated the primary analysis using
quartiles of checklist compliance as the exposure of interest,
using a deviation contrast where the mean compliance for the
whole cohort was treated as the reference category. Secondly,
to identify whether a relationship between checklist use and
postoperative complications or mortality differed according to
income status of the country of origin, we stratified the sample
by country income status (high income or low and middle
income), according to the World Bank definition and repeated
the analysis.20
Evidence synthesis: systematic review and meta-
analysis
We undertook a systematic review and meta-analysis of the
published literature describing the effects of surgical safety
checklist use on patient outcomes, including the results of the
ISOS study. We prospectively registered the systematic review
with PROSPERO (2016:CRD42016039878). The primary outcome
was mortality, which we expected to be the most frequently
reported outcome measure. The secondary outcome was
postoperative complications. Definitions of complications for
included studies are presented in Supplementary Table 1. We
searched MEDLINE, The Cochrane Library, EMBASE, and
CINAHL for the years 2009e2017 using Healthcare Database
Advanced Search (hdas.nice.org.uk). We scanned the bibliog-
raphies of included studies and consulted experts to identify
studies that were missed by the search. Full details of the
search strategy are provided in Supplementary Table 2. We
extracted records to Mendeley (London, UK) to sort and
remove duplicates. Two investigators (M.P. and A.F.) inde-
pendently reviewed each record by title and abstract. Papers
Table 3 Compliance with surgical safety checklist by country and postoperative outcomes. Summary of two separate statistical
models, where the dependent variables were either mortality or any postoperative complication (excluding mortality). Generalized
linear models, with results presented as odds ratios with 95% confidence intervals and P-values. All variables were binary categorical
unless otherwise stated, where exposure to the variable was compared to non-exposure. Checklist compliance, ASA score and grade of
surgery categorical variables where the reference was the average effect across the whole cohort. ASA, American Society of Anes-
thesiologists; COPD, chronic obstructive pulmonary disease
Any complication P-value Mortality P-value
Age (yr) 1.01 (1.00e1.01) <0.01 1.03 (1.02e1.05) <0.01 Male 1.05 (1.02e1.08) <0.01 1.05 (0.90e1.22) 0.58 Female 0.95 (0.93e0.98) <0.01 0.96 (0.82e1.12) 0.58 Present smoker 0.99 (0.92e1.07) 0.84 1.58 (1.10e2.27) 0.01 ASA physical status I 0.54 (0.49e0.58) <0.01 0.09 (0.02e0.40) <0.01 II 0.71 (0.67e0.75) <0.01 0.72 (0.41e1.26) 0.25 III 1.21 (1.14e1.29) <0.01 2.21 (1.29e3.78) <0.01 IV 2.17 (1.92e2.46) <0.01 7.02 (3.87e12.74) <0.01 Grade of surgery Minor 0.52 (0.49e0.56) <0.01 0.64 (0.43e0.94) 0.02 Intermediate 0.91 (0.87e0.96) <0.01 0.91 (0.70e1.19) 0.5 Major 2.10 (2.00e2.20) <0.01 1.72 (1.33e2.22) <0.01 Surgical specialty Orthopaedic 0.89 (0.83e0.96) <0.01 0.65 (0.42e0.99) 0.05 Breast 0.59 (0.49e0.70) <0.01 0.64 (0.17e2.40) 0.51 Obstetrics and gynaecology 0.77 (0.69e0.85) <0.01 0.83 (0.37e1.84) 0.65 Urology and kidney 0.83 (0.76e0.91) <0.01 0.49 (0.26e0.91) 0.02 Upper gastrointestinal 1.37 (1.23e1.53) <0.01 2.69 (1.78e4.08) <0.01 Lower gastrointestinal 1.48 (1.35e1.62) <0.01 1.89 (1.26e2.83) <0.01 Hepatobiliary 0.98 (0.86e1.10) 0.69 1.49 (0.86e2.58) 0.16 Vascular 1.05 (0.93e1.19) 0.45 0.97 (0.57e1.66) 0.92 Head and neck 0.67 (0.62e0.73) <0.01 0.62 (0.35e1.10) 0.11 Plastic or cutaneous 1.01 (0.88e1.17) 0.88 0.95 (0.40e2.26) 0.91 Cardiac 2.49 (2.20e2.81) <0.01 1.60 (1.03e2.49) 0.04 Thoracic (lung and other) 1.25 (1.08e1.45) <0.01 1.15 (0.61e2.19) 0.66 Other 0.68 (0.60e0.77) <0.01 0.74 (0.36e1.54) 0.43 Comorbid disorder Coronary artery disease 1.03 (0.94e0.13) 0.48 0.98 (0.69e1.39) 0.91 Heart failure 1.27 (1.13e1.44) <0.01 1.47 (1.00e2.16) 0.05 Diabetes mellitus 1.10 (1.01e1.19) 0.03 1.26 (0.90e1.75) 0.18 Cirrhosis 1.45 (1.11e1.88) <0.01 2.72 (1.31e5.63) <0.01 Metastatic cancer 1.45 (1.28e1.64) <0.01 3.41 (2.24e5.19) <0.01 Stroke 1.15 (1.01e1.32) 0.03 2.80 (1.88e4.16) <0.01 COPD 1.13 (1.04e1.24) <0.01 1.18 (0.81e1.72) 0.38 Other 1.22 (1.15e1.31) <0.01 1.42 (1.03e1.94) 0.03 Checklist compliance Quartile 1 (low) 1.07 (0.94e1.23) 0.32 1.80 (1.34e2.41) <0.01 Quartile 2 (medium) 1.17 (1.00e1.36) 0.04 1.02 (0.73e1.41) 0.93 Quartile 3 (high) 0.87 (0.75e1.02) 0.09 0.90 (0.61e1.32) 0.58 Quartile 4 (very high) 0.92 (0.81e1.03) 0.15 0.61 (0.45e0.83) <0.01
150 – Abbott et al.
identified as potentially relevant were reviewed in full. Papers
were selected for inclusion if they described the use of the
WHO surgical safety checklist in adult patients (>18 years)
undergoing surgery, and reported either complications or
mortality as postoperative outcomes. We did not include
studies where the surgical safety checklist was tested with
another intervention or where the checklist was modified.21
Differences in opinion were resolved through discussion and
referred to a third investigator (M.G.). Data were extracted
from the selected papers by two independent investigators
(M.P. and A.F.) to a pre-formatted Excel worksheet (Microsoft,
Redmond, WA, USA). The meta-analysis was conducted using
Review Manager Version 5.3 (Cochrane Collaboration, Copen-
hagen, Denmark). Risk of bias was assessed using the
Cochrane tool for randomized controlled trials, the National
Institutes of Health ‘quality assessment of before-and-after
studies’ tool for before and after studies, and the Newcastle
Ottawa Scale for other non-randomized studies.22e24 Between
study heterogeneity was assessed with c2 test and I2 test using
P<0.1 as the pre-defined threshold for statistical significance.
A random effects model was used for all analyses. Results are
presented as OR with 95% CI, associated P-values, and forest
plots.
Results
Surgical safety checklist use in the ISOS cohort
We included 44 814 ISOS participants from 497 hospitals in 27
countries in this analysis (Supplementary Fig. 1). Eight coun-
tries, with 134 participating hospitals, were classed as low- or
middle-income nations.20 Participating hospitals had a me-
dian of 550 (329e850) beds and 21 (10e38) critical care unit
beds. Some 40 245/44 814 (89.8%) patients were exposed to the
surgical safety checklist, 7508/44 814 (16.8%) sustained at least
c
a
rd
ia
c
s
u
rg
e
ry
;
O
S
,
o
rt
h
o
p
a
e
d
ic
O
u
tc
o
m
e
s
M
o
rt
a
li
ty
C
o
m
p
li
c
a
ti
o
n
s
N
Y
N
Y
Y
Y
Y
N
Y
N
N
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
The surgical safety checklist and patient outcomes after surgery – 151
one postoperative complication, and 207/44 814 (0.5%) died
before hospital discharge (Table 1). The results of regression
models for surgical safety checklist exposure against post-
operative mortality or complications in the ISOS cohort are
shown in Table 2. In the unadjusted analysis, exposure to the
surgical safety checklist was associated with a reduction in
mortality [OR 0.42 (0.33e0.58); P<0.01], which remained sta- tistically significant after adjustment for confounding factors
[OR 0.49 (0.32e0.77); P<0.01]. Exposure to the checklist was not associated with a reduction in the incidence of postoperative
complications in either the unadjusted [OR 0.99 (0.91e1.07);
P¼0.74] or the adjusted analyses [OR 1.02 (0.88e1.19); P¼0.75].
a
ly
s
is
.
G
IS
,
g
a
s
tr
o
in
te
s
ti
n
a
l
s
u
rg
e
ry
;
G
S
,
g
e
n
e
ra
l
s
u
rg
e
ry
;
N
C
S
,
n
o
n
–
P
o
p
u
la
ti
o
n
P
a
ti
e
n
ts
,
n
N
o
c
h
e
c
k
li
s
t
C
h
e
c
k
li
s
t
G
S
1
4
4
1
5
0
G
IS
/a
m
p
u
ta
ti
o
n
s
2
0
7
9
7
3
N
C
S
3
7
3
3
3
9
5
5
N
C
S
1
5
2
8
6
3
1
0
3
8
rt
A
n
y
s
u
rg
e
ry
4
0
7
8
1
2
9
8
5
8
rt
N
e
u
ro
s
u
rg
e
ry
2
6
6
5
2
7
5
3
G
S
,
U
S
,
d
a
y
s
u
rg
e
ry
,
e
le
c
ti
v
e
6
0
9
1
8
1
8
G
S
,
U
S
,
O
S
2
2
0
6
4
9
4
A
n
y
p
ro
c
e
d
u
re
1
0
9
3
4
1
1
0
6
3
7
0
rt
N
o
n
-d
a
y
c
a
s
e
s
u
rg
e
ry
1
4
3
6
2
1
1
1
5
1
In
p
a
ti
e
n
t,
e
le
c
ti
v
e
s
u
rg
e
ry
4
5
3
8
4
0
2
4
5
Sensitivity analyses of the ISOS cohort
When countries were ranked by compliance with the check-
list, the mean compliance in the lowest and highest quartiles
were 62.5% and 98.7%, respectively (Supplementary Table 3).
Low checklist use at a national level (quartile 1) was associated
with increased mortality [OR 1.80 (1.34e2.41); P<0.01] and high checklist use at a national level (quartile 4) was associated
with reduced mortality [OR 0.61 (0.45e0.83); P<0.01] (Table 3), with the whole cohort as the reference category. National
rates of checklist use (quartile 1 and quartile 4) were not
associated with any effects on postoperative complication
rates. When we stratified the sample by income status of the
participating country and repeated the primary analysis, the
findings remained similar (Supplementary Tables 4 and 5). To
further explore the absence of association between checklist
use and reduced incidence of postoperative complications, we
conducted a post hoc sensitivity analysis to see if checklist use
was associated with reductions in the incidences of specific
severities of complications (either mild or moderate or severe).
However, we did not identify any such associations
(Supplementary Table 6).
T
a
b
le
4
C
h
a
ra
c
te
ri
s
ti
c
s
o
f
s
tu
d
ie
s
in
c
lu
d
e
d
in
th
e
s
y
s
te
m
a
ti
c
re
v
ie
w
a
n
d
m
e
ta
-a
n
s
u
rg
e
ry
;
P
S
,
p
la
s
ti
c
s
u
rg
e
ry
;
S
S
C
,
s
u
rg
ic
a
l
s
a
fe
ty
c
h
e
c
k
li
s
t;
U
S
,
u
ro
lo
g
ic
s
u
rg
e
ry
S
tu
d
y
re
f
In
p
ri
o
r
re
v
ie
w
?
M
u
lt
ic
e
n
tr
e
S
tu
d
y
d
e
s
ig
n
A
s
k
a
ri
a
n
et
a
l.
3
8
Y
N
B
e
fo
re
/a
ft
e
r
B
li
s
s
et
a
l.
3
9
Y
N
C
a
s
e
/c
o
n
tr
o
l
H
a
y
n
e
s
et
a
l.
4
0
Y
Y
B
e
fo
re
/a
ft
e
r
Ja
m
m
e
r
et
a
l.
1
4
N
Y
P
ro
s
p
e
c
ti
v
e
c
o
h
o
rt
L
a
c
a
s
s
ie
et
a
l.
3
0
N
N
R
e
tr
o
s
p
e
c
ti
v
e
c
o
h
o
L
e
p
a
n
lu
o
m
a
et
a
l.
4
1
N
N
R
e
tr
o
s
p
e
c
ti
v
e
c
o
h
o
L
u
b
b
e
k
e
et
a
l.
4
2
N
N
B
e
fo
re
/a
ft
e
r
M
a
y
e
r
et
a
l.
4
3
N
Y
L
o
n
g
it
u
d
in
a
l
U
rb
a
c
h
et
a
l.
3
4
N
Y
B
e
fo
re
/a
ft
e
r
v
a
n
K
le
i
et
a
l.
4
4
Y
N
R
e
tr
o
s
p
e
c
ti
v
e
c
o
h
o
IS
O
S
G
ro
u
p
N
Y
P
ro
s
p
e
c
ti
v
e
c
o
h
o
rt
Systematic review and meta-analysis
Searches identified 3732 records. After removal of duplicates,
3554 abstracts were screened, 41 full-texts were reviewed, and
11 studies (including ISOS) were selected for inclusion
(Supplementary Fig. 2). Five studies included in previous sys-
tematic reviews were excluded because they did not meet our
inclusion criteria.12,13 A summary of the articles included is
provided in Table 4. A total of 419 799 patients were included in
the meta-analysis for mortality. Some 2624/230 929 (1.1%) of
patients exposed to the checklist died, compared to 2466/188
870 (1.3%) not exposed to the checklist. In the random effects
meta-analysis, checklist exposure was associated with
reduced mortality [OR 0.75 (0.62e0.92); P<0.01; I2¼87%] (Fig. 1). The definition of mortality was ‘in-hospital’ in two studies, in-
hospital restricted to 30 days in five studies, and in-hospital
restricted to 60 days in one study. In contrast, 12 054/161 858
(7.4%) of patients exposed to the checklist developed post-
operative complications, compared to 6043/123 329 (4.9%) of
patients not exposed to the checklist. In the random effects
meta-analysis, checklist exposure was associated with a
reduced incidence of postoperative complications [OR 0.73
(0.61e0.88); P<0.01; I2¼89%] (Fig. 2). The meta-analysis is weighted according to effect size and the two biggest studies,
which account for 38.2% of patients showed no difference in
complication rates between exposed and unexposed patients.
The risk of bias was low in all included studies
(Supplementary Table 7) and visual assessment of funnel plots
Fig 1. Forest plot for meta-analysis of exposure to surgical safety checklist and relative risk of postoperative mortality.
Fig 2. Forest plot for meta-analysis of exposure to surgical safety checklist and relative risk of postoperative complications.
152 – Abbott et al.
demonstrated no evidence of publication bias. Compliance
with checklist use was variable across studies with no pattern
of changing use over time (Supplementary Table 8). To account
for the possibility that some studies in the meta-analysis
included patients exposed to a modified checklist, we
repeated the meta-analysis including five studies of modified
surgical safety checklists that were excluded from the primary
meta-analysis.25e29 Our findings remained similar for both
mortality [OR 0.77 (0.64e0.91]; P<0.01; I2¼83%] and complica- tions [OR 0.71 (0.60e0.84); P<0.01, I2¼92%].
Discussion
The principal finding of this research was that patients
exposed to a surgical safety checklist had a lower incidence of
postoperative complications and death when compared to
patients who were not exposed to a checklist. These findings
may reflect a higher quality of care in hospitals where check-
list use is routine. While the data included in the meta-
analyses are primarily observational, this study adds to the
overall understanding of the surgical safety checklist, indi-
cating that checklists are widely used internationally, but that
in most healthcare settings it is not possible to randomly
assign patients to checklist use because of existing widespread
implementation. Therefore, in the absence of data from ran-
domized trials, our analyses may represent the highest
currently attainable level of evidence describing the effects of
surgical safety checklist use. Future randomized trials may not
be possible, but further research should be standardized for
individual compliance with the checklist. The findings of the
ISOS analysis, where checklist exposure was associated with
reduced mortality but not complications, contrasted with the
results of the meta-analysis. This is counterintuitive, but not
uncommon among meta-analyses, where the results of an
individual study may contrast with the overall weighted effect.
The results of this meta-analysis suggest that across a range of
studies at many hospitals, checklist use is associated with
fewer postoperative complications and deaths. However, it is
unlikely that it will ever be possible to prove the causality of
improved patient outcomes associated with checklist use.
Previous studies in mostly high-income countries have
demonstrated associations between checklist use and reduced
morbidity and mortality. The European Surgical Outcomes
Study, conducted in 426 European hospitals, suggested that
checklist exposure was associated with a 19% reduction in the
relative risk of in-hospital mortality, while a single centre
retrospective cohort study in Chile identified a 27% reduction
in mortality.14,30 However, there is less evidence to support
checklist use in low or middle-income countries.28 Our anal-
ysis of the ISOS is the largest study of which we are aware, to
include data from both low-, middle-/high-income countries.
Our results are therefore more widely generalizable and indi-
cate a need for research and quality improvement to ensure
safe and effective patient care in low- and middle-income
countries. Examples may include rapid response systems
and early warning scores.31e33 The largest study to evaluate
the surgical safety checklist to date was a cohort study of an
implementation project performed in acute care hospitals in
Canada.34 In contrast to our results, the authors did not
identify any benefit associated with checklist use, when
comparing the 3 months before and after implementation in
>200 000 patients. This may be attributable in part to pre-
existing high-quality care at these hospitals. We included
this study in our meta-analysis, which may explain, in part,
The surgical safety checklist and patient outcomes after surgery – 153
the smaller effect estimates than observed in a previous sys-
tematic review.12 Similarly, the findings of the ISOS analysis
contrast with the results of our meta-analysis, which identi-
fied a reduction in postoperative complications associated
with checklist exposure. This might be explained by the high
compliance with checklist use in the ISOS cohort (nine out of
10 patients), making it harder to detect a difference in out-
comes between exposed and non-exposed patients. Alterna-
tively, it may be attributable to bias or heterogeneity between
studies included in the meta-analysis (Supplementary
Table 6).
This work has several strengths. This was a prospective
analysis of the ISOS cohort and a prospective meta-analysis.
ISOS is one of the largest prospective international cohort
studies of surgical outcomes conducted to date, and in
contrast to many other studies, includes data from low-,
middle-, and high-income countries.6 Because of the large
number of patients enrolled, we were able to adjust the anal-
ysis for a variety of potential confounding factors. However, as
with any epidemiological study, we must acknowledge the
potential influence of unmeasured confounding. The meta-
analysis included more than 10 times as many patients as
the previous largest evidence synthesis, and the risk of bias
was lower than in previous work.12,13 Our study also has
several weaknesses. The ISOS investigators hoped to include a
mix of hospitals from each country. However, it is impossible
to say whether the results are representative of practice in any
one country. This is particularly pertinent to low- and middle-
income countries, where there was a bias towards university
hospitals and away from smaller district hospitals. In general,
we would expect hospitals that participate in research to offer
a better standard of care, since research active hospitals tend
to have superior clinical outcomes.35 There is likely to be
heterogeneity of surgical and perioperative care and admin-
istrative procedures across hospitals included in the ISOS
study, which may influence the results. For example, hospitals
in some countries may discharge patients at an earlier stage of
the postoperative pathway than others, which may influence
the rates of recorded in-hospital complications. This is further
illustrated by the variation in compliance with the checklist at
a country level, where three-quarters of countries used the
checklist in >89% of cases, in contrast to a wide variation in
checklist use among countries in the lowest quartile (27e85%).
However, checklist complianceesimilar to the heterogeneity
of surgical care within and between countriese is unlikely to
be uniform across countries and the ISOS sample may not be
representative of country-wide practice. Furthermore, we did
collect data on individual components of the checklist, so it is
possible that some sections were completed more frequently
than others. The meta-analysis did not include studies of staff
training on the use of the surgical safety checklist and we did
not differentiate between different types of complications in
the analysis. The literature describing the checklist describes a
variety of methodologies including randomized trials, pro-
spective and retrospective cohort studies, implementation
studies, and natural trials. We performed a wide-ranging
systematic review and meta-analysis to reflect the breadth
of available knowledge. However, while we were able to in-
crease the precision of our effect size estimates compared to
previous studies, the population samples of included studies
may be different, and this is reflected in the between study
heterogeneity. An alternative approach is to undertake a
meta-analysis based on one methodology only, for example
randomized trials. This approach has been helpful, but is
limited by the number of available studies and therefore pa-
tients.13 Given the inclusion of three large studies in the meta-
analysis, there is the potential that the results may be skewed
towards findings of these studies. We were unable to adjust for
potential improvements in perioperative care over time or
differences in compliance with the checklist between or
within included studies.1,36,37 While several studies have re-
ported compliance rates greater than 90%, the findings of the
included studies do not suggest any trend to improved adop-
tion of the checklist over time.
Conclusions
We have provided evidence to show that patients exposed to a
surgical safety checklist experience better postoperative out-
comes. However, it remains uncertain whether these associ-
ations are a direct causal effect, or if this simply reflects wider
quality of care in hospitals where checklist use is routine.
Authors’ contributions
Study design/plan: T.E.F.A., R.P.
Study draft: T.E.F.A., T.A., A.F., M.G., R.P.
Patient recruitment and data collection: members of the ISOS
study group (see supplementary file).
Analysis of ISOS data: T.A., T.E.F.A.
Systematic review: A.F., M.P., M.G.
Meta-analysis: A.F., T.E.F.A., M.G.
Writing paper: T.E.F.A., A.F., R.P.
Revised paper: all authors.
Acknowledgements
The ISOS study was funded through an unrestricted research
grant from Nestle Health Sciences. T.E.F.A. is supported by a
Medical Research Council/British Journal of Anaesthesia clin-
ical research training fellowship. B.B. is funded by a National
Research Foundation rating grant and an MRC (SA) self-
initiated research grant. M.G. is a Chief Scientist Office (Scot-
land) NHS Research Scheme Clinician. R.P. is a UK National
Institute for Health Research Professor.
Declaration of interest
R.P. holds research grants, and has given lectures and/or per-
formed consultancy work for Nestle Health Sciences, BBraun,
Medtronic, Glaxo SmithKline, and Edwards Lifesciences, and is
a member of the Associate Editorial Board of the British Jour-
nal of Anaesthesia. M.S.C. has received unrestricted research
grants, and has given lectures and/or performed consultancy
work for Thermofisher Scientific, Pulsion Medical Systems,
and Edwards Lifesciences, and is a member of the Associate
Editorial Board of the European Journal of Anaesthesiology. All
other authors declare they have no conflicts of interest.
Supplementary data
Supplementary data related to this article can be found at
https://doi.org/10.1016/j.bja.2017.08.002.
References
1. Weiser TG, Haynes AB, Molina G, et al. Estimate of the
global volume of surgery in 2012: an assessment
https://doi.org/10.1016/j.bja.2017.08.002
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref1
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref1
154 – Abbott et al.
supporting improved health outcomes. Lancet 2015;
385(Suppl 2): S11
2. Kable AK, Gibberd RW, Spigelman AD. Adverse events in
surgical patients in Australia. Int J Qual Health Care 2002;
14: 269e76
3. Mullen R, Scollay JM, Hecht G, McPhillips G,
Thompson AM. Death within 48 headverse events after
general surgical procedures. Surgeon 2012; 10: 1e5
4. Pearse RM, Moreno RP, Bauer P, et al. Mortality after sur-
gery in Europe: a 7 day cohort study. Lancet 2012; 380:
1059e65
5. Weiser TG, Regenbogen SE, Thompson KD, et al. An esti-
mation of the global volume of surgery: a modelling
strategy based on available data. Lancet 2008; 372: 139e44
6. International Surgical Outcomes Study group. Global pa-
tient outcomes after elective surgery: prospective cohort
study in 27 low-, middle- and high-income countries. Br J
Anaesth 2016; 117: 601e9
7. Panesar SS, Cleary K, Sheikh A, Donaldson L. The WHO
checklist: a global tool to prevent errors in surgery. Patient
Saf Surg 2009; 3: 9
8. Gawande AA, Thomas EJ, Zinner MJ, Brennan TA. The
incidence and nature of surgical adverse events in Colo-
rado and Utah in 1992. Surgery 1999; 126: 66e75
9. NHS errors costing billions a year e Jeremy Hunt. 2014.
Available from: http://www.bbc.co.uk/news/uk-29639383.
[Accessed 9
May 2017]
10. WHO surgical safety checklist. 2008. Available from: http://
www.who.int/patientsafety/safesurgery/checklist/en/.
[Accessed 9 May 2017]
11. Putnam LR, Levy SM, Sajid M, et al. Multifaceted in-
terventions improve adherence to the surgical checklist.
Surgery 2014; 156: 336e44
12. Bergs J, Hellings J, Cleemput I, et al. Systematic review and
meta-analysis of the effect of the World Health Organi-
zation surgical safety checklist on postoperative compli-
cations. Br J Surg 2014; 101: 150e8
13. Biccard BM, Rodseth R, Cronje L, et al. A meta-analysis of
the efficacy of preoperative surgical safety checklists to
improve perioperative outcomes. S Afr Med J 2016; 106
14. Jammer I, Ahmad T, Aldecoa C, et al. Point prevalence of
surgical checklist use in Europe: relationship with hospi-
tal mortality. Br J Anaesth 2015; 114: 801e7
15. Vats A, Vincent CA, Nagpal K, Davies RW, Darzi A,
Moorthy K. Practical challenges of introducing WHO surgi-
cal checklist: UK pilot experience. Br Med J 2010; 340, b5433
16. Jammer I, Wickboldt N, Sander M, et al. Standards for
definitions and use of outcome measures for clinical
effectiveness research in perioperative medicine: Euro-
pean Perioperative Clinical Outcome (EPCO) definitions: a
statement from the ESA-ESICM joint taskforce on peri-
operative outcome measures. Eur J Anaesthesiol 2015; 32:
88e105
17. Abbott TE, Ackland GL, Archbold RA, et al. Preoperative
heart rate and myocardial injury after non-cardiac sur-
gery: results of a predefined secondary analysis of the
VISION study. Br J Anaesth 2016; 117: 172e81
18. Abbott TEF, Minto G, Lee A, Pearse RM, Ackland GL.
Elevated preoperative heart rate is associated with car-
diopulmonary and autonomic impairment in high-risk
surgical patients. Br J Anaesth 2017; 119: 87e94
19. Ackland GL, Abbott TEF, Pearse RM, Karmali S, Whittle J.
Pulse pressure and postoperative morbidity in high-risk
surgical patients. Br J Anaesth 2018; 120: 94e100
20. World Bank Country and Lending Groups. Available from:
https://datahelpdesk.worldbank.org/knowledgebase/
articles/906519-world-bank-country-and-lending-groups.
[Accessed 9 February 2017].
21. Kwok AC, Funk LM, Baltaga R, et al. Implementation of the
World Health Organization surgical safety checklist,
including introduction of pulse oximetry, in a resource-
limited setting. Ann Surg 2013; 257: 633e9
22. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane
Collaboration’s tool for assessing risk of bias in rando-
mised trials. Br Med J 2011; 343, d5928
23. Stang A. Critical evaluation of the Newcastle-Ottawa scale
for the assessment of the quality of nonrandomized
studies in meta-analyses. Eur J Epidemiol 2010; 25: 603e5
24. NIH. Quality assessment tool for before-after (pre-post) studies
with no control group. 2017. Available from: https://http://
www.nhlbi.nih.gov/health-pro/guidelines/in-develop/car
diovascular-risk-reduction/tools/before-after. [Accessed 2
May 2017]
25. Biskup N, Workman AD, Kutzner E, Adetayo OA, Gupta SC.
Perioperative safety in plastic surgery: is the World Health
Organization checklist useful in a broad practice? Ann
Plast Surg 2016; 76: 550e5
26. Boaz M, Bermant A, Ezri T, et al. Effect of surgical safety
checklist implementation on the occurrence of post-
operative complications in orthopedic patients. Isr Med
Assoc J 2014; 16: 20e5
27. Bock M, Fanolla A, Segur-Cabanac I, et al. A comparative
effectiveness analysis of the implementation of surgical
safety checklists in a tertiary care hospital. JAMA Surg
2016; 151: 639e46
28. Chaudhary N, Varma V, Kapoor S, Mehta N,
Kumaran V, Nundy S. Implementation of a surgical
safety checklist and postoperative outcomes: a pro-
spective randomized controlled study. J Gastrointest
Surg 2015; 19: 935e42
29. Haugen AS, Softeland E, Almeland SK, et al. Effect of the
World Health Organization checklist on patient outcomes:
a stepped wedge cluster randomized controlled trial. Ann
Surg 2015; 261: 821e8
30. Lacassie HJ, Ferdinand C, Guzman S, Camus L,
Echevarria GC. World Health Organization (WHO) surgical
safety checklist implementation and its impact on peri-
operative morbidity and mortality in an academic medical
center in Chile. Medicine 2016; 95: e3844
31. Abbott TE, Torrance HD, Cron N, Vaid N, Emmanuel J.
A single-centre cohort study of National Early Warning
Score (NEWS) and near patient testing in acute medical
admissions. Eur J Int Med 2016; 35: 78e82
32. Abbott TE, Vaid N, Ip D, et al. A single-centre observa-
tional cohort study of admission National Early Warning
Score (NEWS). Resuscitation 2015; 92: 89e93
33. McGinley A, Pearse RM. A national early warning score for
acutely ill patients. Br Med J 2012; 345, e5310
34. Urbach DR, Govindarajan A, Saskin R, Wilton AS,
Baxter NN. Introduction of surgical safety checklists in
Ontario, Canada. N Engl J Med 2014; 370: 1029e38
35. Ozdemir BA, Karthikesalingam A, Sinha S, et al. Research
activity and the association with mortality. PLoS One 2015;
10, e0118253
36. Abbott TEF, Fowler AJ, Dobbs T, et al. Frequency of sur-
gical treatment and related hospital procedures in the
United Kingdom: A national ecological study using hos-
pital episode statistics. Br J Anaesth 2017; 119: 249e57
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref1
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref1
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref2
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref2
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref2
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref2
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref3
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref3
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref3
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref3
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref3
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref4
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref4
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref4
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref4
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref5
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref5
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref5
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref5
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref6
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref6
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref6
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref6
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref6
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref7
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref7
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref7
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref8
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref8
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref8
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref8
http://www.bbc.co.uk/news/uk-29639383
http://www.who.int/patientsafety/safesurgery/checklist/en/
http://www.who.int/patientsafety/safesurgery/checklist/en/
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref11
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref11
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref11
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref11
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref12
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref12
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref12
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref12
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref12
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref13
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref13
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref13
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref14
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref14
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref14
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref14
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref15
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref15
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref15
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref16
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref17
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref17
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref17
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref17
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref17
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref18
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref18
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref18
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref18
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref18
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref19
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref19
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref19
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref19
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref21
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref21
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref21
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref21
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref21
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref22
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref22
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref22
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref23
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref23
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref23
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref23
https://http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/before-after
https://http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/before-after
https://http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/before-after
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref25
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref25
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref25
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref25
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref25
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref26
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref26
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref26
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref26
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref26
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref27
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref27
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref27
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref27
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref27
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref28
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref29
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref29
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref29
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref29
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref29
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref30
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref30
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref30
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref30
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref30
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref31
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref31
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref31
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref31
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref31
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref32
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref32
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref32
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref32
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref33
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref33
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref34
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref34
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref34
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref34
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref35
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref35
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref35
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref36
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref36
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref36
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref36
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref36
The surgical safety checklist and patient outcomes after surgery – 155
37. Kahan BC, Koulenti D, Arvaniti K, et al. Critical care
admission following elective surgery was not associated
with survival benefit: prospective analysis of data from 27
countries. Intensive Care Med 2017; 43: 971e9
38. Askarian M, Kouchak F, Palenik CJ. Effect of surgical safety
checklists on postoperative morbidity and mortality rates,
Shiraz, Faghihy Hospital, a 1-year study. Qual Manag
Health Care 2011; 20: 293e7
39. Bliss LA, Ross-Richardson CB, Sanzari LJ, et al. Thirty-day
outcomes support implementation of a surgical safety
checklist. J Am Coll Surg 2012; 215: 766e76
40. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety
checklist to reduce morbidity and mortality in a global
population. N Engl J Med 2009; 360: 491e9
41. Lepanluoma M, Rahi M, Takala R, Loyttyniemi E,
Ikonen TS. Analysis of neurosurgical reoperations: use of
a surgical checklist and reduction of infection-related and
preventable complication-related reoperations.
J Neurosurg 2015; 123: 145e52
42. Lubbeke A, Hovaguimian F, Wickboldt N, et al. Effective-
ness of the surgical safety checklist in a high standard
care environment. Med Care 2013; 51: 425e9
43. Mayer EK, Sevdalis N, Rout S, et al. Surgical Checklist
Implementation Project: the impact of variable WHO
checklist compliance on risk-adjusted clinical outcomes
after national implementation: a longitudinal study. Ann
Surg 2016; 263: 58e63
44. van Klei WA, Hoff RG, van Aarnhem EE, et al. Effects of the
introduction of the WHO “Surgical Safety Checklist” on in-
hospital mortality: a cohort study. Ann Surg 2012; 255:
44e9
Handling editor: P.S. Myles
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref37
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref37
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref37
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref37
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref37
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref38
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref38
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref38
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref38
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref38
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref39
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref39
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref39
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref39
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref40
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref40
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref40
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref40
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref41
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref42
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref42
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref42
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref42
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref43
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref44
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref44
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref44
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref44
http://refhub.elsevier.com/S0007-0912(17)53945-8/sref44
Methods
ISOS analysis: design, setting, and participants
ISOS analysis: outcome measures
ISOS analysis: statistical methods
ISOS analysis: sensitivity analyses
Evidence synthesis: systematic review and meta-analysis
Results
Surgical safety checklist use in the ISOS cohort
Sensitivity analyses of the ISOS cohort
Systematic review and meta-analysis
Discussion
Conclusions
Authors’ contributions
Acknowledgements
Declaration of interest
Supplementary data
References